Sokolove Law

Sokolove Law
About Us
Quotes
Share:
Subscribe:

About Us

Sokolove Law, LLC is the nation’s largest marketer of legal services that help people obtain access to the civil justice system while ensuring they receive superior quality legal representation. With over 30 years of service, Sokolove Law has helped thousands of injured parties obtain the compensation they deserve from their legal claim such as mesothelioma, cerebral palsy, nursing home abuse, dangerous drugs, disability insurance denial, and medical malpractice cases.

Quotes

“Our heartfelt condolences go out to Larry’s family. He was a great man who brought the Mesothelioma Community together around the country year in and year out in order to raise awareness of asbestos health dangers. We will honor Larry’s memory and tremendous community efforts by remaining committed to supporting the cause for which he was so passionate about.”

Jim Sokolove, Founder

“Sokolove Law is fortunate to have known Larry and we thank his daughter Courtney and the rest of the Davis family for sharing his story and impacting countless other lives around the country. He will be sorely missed.”

Ricky LeBlanc, Managing Attorney, Asbestos, Sokolove Law

For more than 30 years, Sokolove Law has helped children of families who have been impacted by cerebral palsy, Erb’s palsy (also known as Brachial Plexus injury), and other birth-related injuries. The firm has helped people in all 50 states get the legal support they need to move personal injury claims successfully through the court system. ChildBirthInjuries.com is great new resource for parents and their families.”

Jim Sokolove, founder

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

Vistide Recall for Particulate Matter

Tue, Feb 26, 2013 17:00 CET

Gilead Sciences Inc. voluntarily recalled one lot of Vistide (cidofovir injection) over a possible contamination with visible particulate matter. The recall is for lot number B120217A, according to the Food and Drug Administration . The recalled product is clear, colorless, and supplied in clear glass vials. It is used in the treatment of cytomegalovirus (CMV) retinitis in AIDS patients. Gilead said it is not currently aware of any complaint attributable to the particles. The

First Actos Bladder Cancer Lawsuit Starts

Fri, Feb 22, 2013 01:00 CET

The first trial over the alleged bladder cancer risk of Takeda Pharmaceutical’s diabetes drug , Actos , gets underway this week in state court in Los Angeles. Bloomberg reports the company is facing more than 3,000 lawsuits around the country

Reumofan Plus Tablets Recalled

Thu, Feb 21, 2013 15:52 CET

A recall of Reumofan Plus Tablets was issued by Reumofan Plus USA, LLC and Reumofan USA, LLC because the tablets contain undeclared drug ingredients that can cause grave injuries. Reumofan Plus tablets are used for conditions such as muscle pain, arthritis, osteoporosis, and bone cancer. According to the Food and Drug Administration (FDA), the hazardous active ingredients in the pain killer include methocarbamol, dexamethasone, and diclofenac. The FDA has received one report of illness associated with the product. The recalled

Drugmaker to Pay $63 Million in Motrin Lawsuit

Tue, Feb 19, 2013 01:00 CET

A Massachusetts jury awarded $63 million to a teenager and her parents for injuries the girl suffered after using a children’s pain reliever made by Johnson & Johnson (J&J) when she was just seven years old. The Associated Press (AP) reports that a Plymouth Superior Court jury asked J&J and its McNeil-PPC Inc. subsidiary to pay the girl and her parents a total of $109 million, including interest. The girl was given Motrin brand ibuprofen to reduce a fever

Merck Loses Fosamax Trial Verdict

Wed, Feb 13, 2013 18:00 CET

In a court room upset, Merck & Co. Inc. lost its second Fosamax lawsuit to a New York resident who claimed she suffered jaw injury due to the side effects of the osteoporosis drug. Reuters reports that the jury awarded the plaintiff $285,000 in the case, which was originally filed in 2008 in U.S District Court in Manhattan. The lawsuit alleged the plaintiff suffered delayed healing and a bone disease of the jaw following dental work because of the company’s

Acetaminophen OD Fatal for Almost 100 Annually

Wed, Feb 13, 2013 15:00 CET

A large dose of acetaminophen , taken all at once or over a short period of time, may lead to severe liver damage, liver collapse or death, according to the Clinical Center for Liver Diseases at the University of Texas Southwestern Medical Center in Dallas. Center director Dr. William Lee notes that since acetaminophen is present in drugs for headache relief, flu formulas, sleeping pills

Zoloft Lawsuit Claims Drug is Ineffective

Fri, Feb 08, 2013 16:00 CET

A lawsuit filed against drug giant Pfizer Inc. has claimed that its antidepressant drug Zoloft has no benefit for patients and that the company should refund patients for the costs of buying the drug. The Associated Press

Judge Freezes Assets of Meningitis Pharmacy Owners

Sat, Feb 02, 2013 03:00 CET

The personal assets of the owners of the Massachusetts compounding pharmacy linked to the recent deadly meningitis outbreak were temporarily frozen by a bankruptcy judge in response to an emergency motion by a committee of the company’s creditors. Reuters reports that the order means that the owners of the New England Compounding Center (NECC) are temporarily prohibited from selling their luxury homes or

Hospira Recalls IV Solution over Mold Concerns

Sat, Feb 02, 2013 02:00 CET

Hospira Inc. initiated a nationwide recall for one lot of an intravenous solution after receiving a customer report of a spore-like matter resembling a mold found in the solution. The recalled product is called Lactated Ringers and 5% Dextrose Injection, according to the U.S. Food and Drug Administration (FDA). It is used as a source of water, electrolytes, and calories or as an alkalizing agent in patients. The details of the packaging of the recalled lot of 5% Dextrose Injection include: • 1000 ml flexible container • lot number:

Five Tylenol Liver Damage Lawsuits Filed

Mon, Jan 21, 2013 14:00 CET

Five Tylenol liver damage lawsuits were filed against Johnson & Johnson (J&J) in Pennsylvania state court last week. Law360 (subscription required) reports that the suits claim that the painkiller acetaminophen found in various Tylenol

Study Suggests Higher Death Risk with Heart Drug

Wed, Dec 05, 2012 15:00 CET

A new study says that people suffering from an abnormal heart rhythm, also known as atrial fibrillation, may be at a greater risk of dying sooner if they have been prescribed the popular heart drug digoxin for the treatment. According to Reuters Health

FDA Diarrhea Drug Warning for Intestinomicina

Mon, Sep 24, 2012 19:00 CET

The U.S. Food and Drug Administration (FDA) has issued a warning to not use Intestinomicina—a drug made in El Salvador to treat diarrhea and acute gastrointestinal infections—due to the presence of chloramphenicol, which can cause severe and life-threatening injuries. According to the FDA , chloramphenicol can cause bone marrow toxicity. Bone marrow toxicity occurs when the body fails to produce enough red blood cells, white blood cells, or platelets. Patients who use Intestinomicina and are suffering from anemia,

Some Omega-3 Supplements Mislead on Labels

Tue, Sep 04, 2012 18:30 CET

New research by a consumer group finds that some dietary supplements containing omega-3 fatty acids mislead consumers about their ingredients. Consumerlab.com found in laboratory tests of 35 supplements that 31 percent did not contain the amount of healthy fatty acids that their labels claimed they did, according to Medical Daily . Studies have found omega-3 fatty acids can improve heart

FDA Issues New Safety Alert on Reumofan

Tue, Aug 28, 2012 00:30 CET

The Food and Drug Administration (FDA) issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions. The FDA says it has received dozens of additional adverse event reports of bleeding, stroke, liver damage and death among users of Reumofan Plus and Reumofan

Drugs for Kids Often Go Untested

Wed, May 09, 2012 19:00 CET

According to a recent report in the Pediatrics journal, four out of every five children hospitalized in the U.S. are given medications that have never been tested in them. Most of the drugs used on children are approved by the Food and Drug Administration for adults and about 33 percent of kids take these types of medications, according to CNN . It is legal for doctors to prescribe

Hormone Use May increase Risk of Breast Cancer

Mon, Apr 09, 2012 21:59 CET

A new study suggests that any type of hormone therapy may raise the risk of breast cancer in women who take the medications for longer than 10 years. Researchers at the Dana-Farber Cancer Institute tracked the health of close to 60,000 women and found that those who used hormone therapy for 10 years or more had an increased risk of developing breast cancer. The study showed that the risk for breast cancer

Lawmaker Introduces Bill for Generic Drugs

Wed, Apr 04, 2012 17:19 CET

The safety of consumers taking generic drugs may be threatened by a recent Supreme Court decision, and Sen. Patrick Leahy (D-VT) will not stand for it. Leahy will introduce legislation in an attempt to reverse the decision - Pilva v. Mensing - that allows generic drug manufacturers to use the same label as a brand name version, even if the company knows that the warning on the label is inadequate. “The [Pilva v. Mensing] decision creates a troubling inconsistency in the law

FDA Updates Celexa Dosing and Warnings

Tue, Apr 03, 2012 21:30 CET

The Food and Drug Administration clarified dosing and warning recommendations for the SSRI antidepressant Celexa (citalopram hydrobromide) due to the risk of adverse side effects. In August 2011, the agency announced that

There are no items matching the current filter

There are no more items matching the current filter

Share